HISTOGEN INC.

Profile

Company Names

HISTOGEN INC.
CONATUS PHARMACEUTICALS INC

Addresses

10655 SORRENTO VALLEY ROAD, SUITE 200, SAN DIEGO, CA 92121

4365 EXECUTIVE DIRVE, SUITE 200, SAN DIEGO, CA 92121

4365 EXECUTIVE DRIVE, SUITE 200, SAN DIEGO, CA 92121

Phone Numbers

(858) 526-3100
(858) 457-7221

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$36,466,266.00

Number of Funding Rounds:

5
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
5
2022-07-14 
$5,000,000.00 
$5,000,000.00 
$0.00 
 
4
2020-11-16 
$189,208.00 
$189,208.00 
$0.00 
 
3
2013-05-30 
$1,001,551.00 
$1,001,551.00 
$0.00 
Debt 
2
2011-02-09 
$25,275,507.00 
$25,275,507.00 
$0.00 
Equity 
1
2010-03-05 
$5,000,000.00 
$5,000,000.00 
$0.00 
Debt 
People
First Name
Middle Name
Last Name
Titles
Related Companies
GARY 
C. 
BURGESS 
EXECUTIVE OFFICER
CHARLES 
J. 
CASHION 
EXECUTIVE OFFICER
JENNIFER 
GIOTTONINI 
CAYER 
EXECUTIVE OFFICER
STEPHEN 
 
CHANG, PH.D. 
DIRECTOR
DAVID 
H. 
CREAN 
DIRECTOR
DAVID 
 
CREAN, PH.D. 
DIRECTOR
MOYA 
 
DANIELS 
EXECUTIVE OFFICER
ROCHELLE 
 
FUHRMANN 
DIRECTOR
WILLIAM 
 
GERBER 
DIRECTOR
WILLIAM 
 
GERBER, M.D. 
DIRECTOR
DANIEL 
L. 
KISNER 
DIRECTOR
DANIEL 
 
KISNER, M.D. 
DIRECTOR
PAUL 
H. 
KLINGENSTEIN 
DIRECTOR
SUSAN 
A. 
KNUDSON 
EXECUTIVE OFFICER
MARTIN 
 
LATTERICH 
EXECUTIVE OFFICER
SHAHZAD 
 
MALIK, M.D. 
DIRECTOR
STEVEN 
J. 
MENTO 
EXECUTIVE OFFICER, DIRECTOR
STEVEN 
 
MENTO, PH.D. 
DIRECTOR
STEVEN 
J. 
MENTO, PH.D. 
EXECUTIVE OFFICER, DIRECTOR
GAIL 
 
NAUGHTON 
EXECUTIVE OFFICER
GAIL 
K. 
NAUGHTON 
EXECUTIVE OFFICER
RICHARD 
W. 
PASCOE 
EXECUTIVE OFFICER, DIRECTOR
MARC 
 
PERET 
DIRECTOR
MARC 
 
PERRET 
DIRECTOR
JOYCE 
 
REYES 
EXECUTIVE OFFICER
BRIAN 
 
SATZ 
DIRECTOR
BRIAN 
 
SATZ, ESQ. 
DIRECTOR
ALFRED 
P. 
SPADA 
EXECUTIVE OFFICER
ALFRED 
P. 
SPADA, PH.D. 
EXECUTIVE OFFICER
HAROLD 
 
VAN WART 
DIRECTOR
HAROLD 
 
VAN WART, M.D. 
DIRECTOR
SUSAN 
 
WINDHAM-BANNISTER 
DIRECTOR
HAYDEN 
YIZHUO 
ZHANG 
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2022-07-14 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2020-11-16 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2013-05-30 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-02-09 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2010-03-05 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
H.C. WAINWRIGHT + CO., LLC
375
NONE
NONE
H.C. WAINWRIGHT + CO., LLC
375